Bachem Holding AG (SWX:BANB)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
63.60
+0.05 (0.08%)
Sep 5, 2025, 5:30 PM CET
0.08%
Market Cap4.76B
Revenue (ttm)677.93M
Net Income (ttm)134.19M
Shares Out74.97M
EPS (ttm)1.80
PE Ratio35.38
Forward PE32.62
Dividend0.85 (1.34%)
Ex-Dividend DateMay 5, 2025
Volume124,393
Average Volume70,536
Open64.05
Previous Close63.55
Day's Range63.30 - 64.85
52-Week Range43.34 - 79.10
Beta0.83
RSI45.10
Earnings DateMar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an... [Read more]

Industry Chemicals
Sector Materials
Founded 1971
Employees 2,207
Stock Exchange SIX Swiss Exchange
Ticker Symbol BANB
Full Company Profile

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial Statements

News

Bachem Holding AG (BCHMF) (Q4 2024) Earnings Call Highlights: Surpassing Financial Goals Amid ...

Bachem Holding AG (BCHMF) (Q4 2024) Earnings Call Highlights: Surpassing Financial Goals Amid Expansion and Sustainability Efforts

6 months ago - GuruFocus

Full Year 2024 Bachem Holding AG Earnings Call Transcript

Full Year 2024 Bachem Holding AG Earnings Call Transcript

6 months ago - GuruFocus